Kidney Disease Clinical Trials

Showing 3621-3640 of 3,902 trials

Intradialytic Progressive Resistance Training for Maintenance Haemodialysis Patients

NCT01007838

The purpose of this study is to investigate the effects of a 12 week progressive resistance training during haemodialysis on muscle quantity and physical functioning in chronic kidney disease patients receiving maintenance haemodialysis. It is hypothesised, based on previous literature involving similar resistance training protocols in other catabolic conditions, that the resistance training will result in a significant increase in muscle quantity as well a physical function.

Chronic Kidney Disease

Bangor University32 participantsStarted Jan 2009

Bangor, Gwynedd, United Kingdom

UNKNOWN

Early Diagnosis of Postoperative Acute Renal Failure-using Biomarker to Predict Outcome of Cardiac Surgery Associated Acute Kidney Injury

NCT01503710

The purpose of this study is to determine soluble HJV could be an early diagnosis urinary biomarker of ischemia/reperfusion injury in post CPB-patients.

Acute Renal FailureAcute Kidney Injury

National Taiwan University Hospital200 participantsStarted Jun 2011

Taipei, Taiwan, Taiwan

TERMINATEDPhase 2

Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma

NCT00561912

Primary Objective: * To determine the progression-free survival (PFS) times for patients with advanced renal cell carcinoma (RCC) treated with decitabine and interferon alfa-2b. Secondary Objectives: * To determine the toxicity of the combination of decitabine and interferon alfa-2b at the proposed dose and schedule in patients with advanced RCC * To determine overall response by Response Evaluation Criteria in Solid Tumors (RECIST) criteria for patients with advanced RCC treated with decitabine and interferon alfa-2b. * To determine the overall survival times for patients with advanced RCC treated with decitabine and interferon. * To study the effects of decitabine and interferon alfa-2b on DNA methylation and gene expression in patients' tumor and non-tumor tissues and their correlation with clinical outcomes. * To characterize the modulation of cellular immunity induced by the combination of decitabine and interferon alfa-2b in patients with advanced RCC and to correlate these results with clinical outcomes.

Renal Cell Carcinoma

M.D. Anderson Cancer Center2 participantsStarted Oct 2007

Houston, Texas, United States

Intradialytic Progressive Resistance Training for Maintenance Haemodialysis Patients

Early Diagnosis of Postoperative Acute Renal Failure-using Biomarker to Predict Outcome of Cardiac Surgery Associated Acute Kidney Injury

Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma

Related Searches

Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation

A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.

Adrenalectomy for Solitary Adrenal Gland Metastases

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome

Dendritic Cell Based Therapy of Renal Cell Carcinoma

Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection

A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)

Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose

Dietary and Dialysate Sodium Reduction on Body Fluid Volume and Inflammatory State in Hemodialysis Patients

Are we Loading Our Patients With Sodium During Hemodialysis Treatments?